What CET Group does

CET Group is a private engineering consultancy founded in 2000 and headquartered in Geelong, Australia. The firm provides process engineering, mechanical design, and validation services to clients operating in highly regulated industries, with disclosed focus areas spanning pharmaceuticals, biotechnology, containment systems, water systems, and fine chemicals. CET operates on a project-based services model, executing engineering engagements for enterprise clients in capital-intensive, GMP-relevant production environments, and has additionally productized internal IP via a patent on the Biotap technology platform.

The company's revenue mechanics are tied to project fees on multi-year capital programs, with disclosed individual project values ranging from approximately $6 million to $165 million. CET's client base is concentrated among a small set of named enterprise accounts, most prominently CSL Behring (a global biopharmaceutical manufacturer) across multiple large engagements, with Dulux Group representing a secondary reference in industrial coatings manufacturing. With a headcount in the 11-50 range, the firm functions as a mid-sized specialist consultancy rather than a tier-1 engineering, procurement, and construction (EPC) generalist, and competes on deep domain expertise in regulated process environments rather than scale.

CET's competitive position rests on a 25-year track record of qualified system design, validation, and process engineering delivered within the documentation and compliance frameworks demanded by pharmaceutical and bioprocessing clients. The patented Biotap technology indicates modest productization of in-house engineering know-how, though services remain the dominant revenue driver. No funding rounds, acquisitions, divestitures, leadership changes, or material strategic pivots are visible in the available data, consistent with a stable, organically grown specialist firm operating in a niche corner of the engineering services market.

Name

CET Group

Legal name

CET Group

Website

https://cetgroup.com.au

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

CET Group is a Geelong, Australia-based engineering consultancy founded in 2000 that delivers process engineering, mechanical design, and validation services to pharmaceutical, biotechnology, containment, water, and fine chemicals clients, with patented Biotap technology and project engagements ranging from $6M to $165M.

Ownership category

akta.pro rank

Headquarters

HQ city

Geelong

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Revenue model

1. Engineering Consulting Services: CET Group generates revenue through professional engineering consulting services. This includes project engineering, design drafting, process modelling, feasibility studies, technical writing, commissioning, and validation services. Revenue is project-based, typically spanning from concept development through to validation and handover. The company works on specific tasks or runs entire projects for clients in regulated industries.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

CET Group is a mechanical engineering consultancy delivering process, mechanical, and validation engineering services for regulated industries including pharmaceuticals, biotechnology, water, containment, clean rooms, paint/ink/fine chemicals, and food/beverage/dairy. The firm supports full project lifecycles from concept design and feasibility studies through detailed drafting, 3D modelling, commissioning, and validation, with regulatory compliance expertise spanning TGA, FDA, EU, OGTR, and AQIS standards.

Product overview

CET Group is an engineering consultancy (founded in 2000) offering specialized services across pharmaceutical, biotech, water treatment, containment, clean room, and industrial process industries. The company does not offer a unified software product but provides a portfolio of engineering and consulting services including Design Drafting & 3D Modelling (using AutoCAD, Inventor, Plant 3D, Navisworks), Process Modelling, Project Engineering, Validation, Commissioning, Technical Writing, Feasibility Studies, Noise Control, and Mechanical Services Design. Additionally, CET Group holds patents for the Biotap - a Patented Bacterial Controlled Outlet system for controlling microbiological contamination in pharmaceutical and healthcare water systems. Water treatment systems cover the full spectrum from Process Water through to Water for Injection (WFI), with specialized UV/Ozone/Chemical scrubbing capabilities. The service offering is delivered through experienced engineering teams serving clients in Australia and international markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Process Engineering

Quantifiable outcome

• Delivered World's Largest Flexible Cell Culture Facility in Australia, later used for COVID vaccine production
• +2 more outcomes

Named customers6 records

Segments8 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• CRB: US-headquartered engineering, architecture, and construction firm specialising in life sciences facilities (pharma, biotech, cell/gene therapy). Most directly comparable peer to CET in regulated facility design, process engineering, and validation.
• IPS (Integrated Project Services): Global EPCM firm focused exclusively on life sciences — designs, builds, and validates pharma and biotech manufacturing facilities. Highly comparable to CET's pharma/biotech engineering, clean room, and validation offering.
• Genesis AEC: US-based architectural, engineering, and consulting firm dedicated to life sciences manufacturing, with deep pharma and biotech facility design credentials. Closely comparable niche life-sciences engineering focus.
• DPS Group: Global engineering and validation services provider to the pharmaceutical, biopharma, and medtech sectors. Directly comparable for process, mechanical, commissioning, and validation services.

Emerging players

• PharmEng Technology: Pharmaceutical engineering consultancy offering commissioning, qualification, and validation services to drug manufacturers. Comparable niche validation/process engineering capability, smaller scale.

Regional players

• Aurecon: Major Australian-headquartered engineering and infrastructure advisory. Comparable as a domestic Australian engineering consultancy with life-sciences and industrial process exposure, though significantly larger and broader.
• GHD: Large Australian engineering, architecture, and environmental consulting firm with a life-sciences practice. Comparable as a domestic peer serving regulated industries with multidisciplinary engineering capability.

Broad incumbents

• Worley: Australian-headquartered global engineering and project delivery firm with pharma, biotech, and process industry exposure. Comparable at the process-engineering level, though broader and substantially larger.
• AECOM: Global infrastructure consulting firm with a life-sciences and industrial process practice offering engineering and construction services. Overlaps with CET in regulated facility design but at vastly greater scale.
• Jacobs: Global professional services and engineering firm with life-sciences, advanced facilities, and critical environment practices. Comparable in regulated facility design and validation, but much larger and broader in scope.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cetgroup-australia

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CET Group